Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 531541 | NSE Symbol : | ISIN : INE881A01015 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
12-Aug-2024	14-Aug-2024	Quarterly Results	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday 14th August 2024 inter alia to consider and approve the unaudited financial results of the Company for the quarter ended 30th June 2024 along with the Limited Review report of the auditor thereon. The board of Directors of the Company has today approved the Unaudited Financial Result for the quarter ended 30th June, 2024 along with the Limited review report of auditor thereon. (As per BSE Announcement dated on 14/08/2024)
23-May-2024	30-May-2024	Accounts	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve the audited Financial Statement for the quarter and year ended 31st March 2024 Board of Directors of Kobo Biotech Limited at their meeting held today i.e. on Thursday, 30th May, 2024 inter alia approved the audited financial results for the Quarter and the year ended 31st March, 2024 alongwith the report of statutory auditor thereon. Read less.. (As Per BSE Announcement Dated on 30.05.2024)
07-Feb-2024	14-Feb-2024	Quarterly Results	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the unaudited financial statements for the quarter and nine months ended 31st December 2023 Financial Results for the Quarter and Nine Months ended 31st December, 2023 (As Per BSE Announcement Dated on 14/02/2024)
03-Nov-2023	10-Nov-2023	Accounts	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve the unaudited financial result for the 2nd Quarter and half year ended 30th September 2023. The Board of Director of the company at their meeting held today i.e. 10th November, 2023 inter alia approved the unaudited financials results for the quarter and half year ended 30th September, 2023 (As Per BSE Announcement Dated on 10.11.2023)
03-Aug-2023	11-Aug-2023	Quarterly Results	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 11th August 2023 inter alia to consider and approve the unaudited financial results of the Company for the 1st quarter ended 30th June 2023. This is to inform you that the Board of Directors of Kobo Biotech Limited at their meeting held today i.e. on Friday, 11th August, 2023 inter alia approved the Unaudited Financial Results of the Company for the quarter ended 30th June, 2023 alongwith the Limited review report of statutory auditor thereon. Please find enclosed a copy of the unaudited Financials along with Limited Review report from the Statutory Auditors. Further, we wish to inform you that Board of Directors of the Company based on the recommendation of the Nomination and Remuneration Committee and subject to the approval of the Members of the Company, has approved the proposals for the reappointment of Mrs. Urja Vijaykumar Shah, (DIN: 06672899), as an Independent Director of the Company, for a second term of Five years from 27th December, 2023 to 26th December, 2028. The Board of Director of the company has approved the Unaudited Financial Result for the quarter ended 30th June, 2023 The board of director of the Company has approved the proposal for re-appointment of Ms. Urja Shah as an independent Director for 2nd term of five years, subject to the approval of the members. (As Per BSE Announcement Dated on 11.08.2023)
24-May-2023	30-May-2023	Accounts	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday 30th May 2023 inter alia to consider and approve the audited financial results of the Company for the quarter and year-ended 31st March 2023 along with the report of statutory auditor thereon. This is to inform you that the Board of Directors of Kobo Biotech Limited at their meeting held today i.e. on Tuesday, 30th May, 2023 inter alia approved the Audited Financial Results of the Company for the quarter and year ended 31st March, 2023 alongwith the report of statutory auditor thereon. (As Per BSE Announcement Dated on 30.05.2023)
06-Feb-2023	13-Feb-2023	Quarterly Results	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve the Unaudited Financial Results along with the Limited Review Report for the quarter and nine-months ended December 31 2022. This is to inform you that the Board of Directors of Kobo Biotech Limited at their meeting held today i.e. on Monday, 13th February 2023 inter alia approved the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2022 along with the Limited review report of statutory auditor thereon. We wish to inform you that the Board of Directors of the Company at their meeting held today i.e., 13th February 2023, based on the recommendation of the Nomination and Remuneration Committee and subject to the approval of the Members of the Company, has approved the proposals for re-appointment of Mr. Abhishek Buddhadev, (DIN: 07673161), as an Independent Director of the Company, for a second term of Five years from 1st April 2023till 31st March 2028 and also approved the proposal for re-appointment of Dr. Sunil Pitroda, (DIN:07028212), as an Independent Director of the Company, for a second term of Three years from 1st April 2023 till 31st March 2026. (As Per BSE Announcement Dated on 13/02/2023)
07-Nov-2022	14-Nov-2022	Quarterly Results	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday 14th November 2022 inter alia to consider and approve the unaudited financial results of the Company for the half year and 2nd quarter ended 30th September 2022. The Board of Directors of Kobo Biotech Limited at their meeting held today i.e. on Monday, 14th November, 2022 inter alia approved the Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2022 along with the Limited review report of statutory auditor thereon. (As Per BSE Announcement Dated on 14.11.2022)
04-Aug-2022	11-Aug-2022	Quarterly Results	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2022 inter alia to consider and approve the unaudited financial results of the Company for the 1st quarter ended 30th June 2022. This is to inform you that the Board of Directors of Kobo Biotech Limited at their meeting held today i.e. on Thursday, 11th August, 2022 inter alia approved the Unaudited Financial Results of the Company for the quarter ended 30th June, 2022 alongwith the Limited review report of statutory auditor thereon. (As Per BSE Announcement Dated 11.08.2022)
23-May-2022	30-May-2022	Accounts	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 inter alia to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday 30th May 2022 inter alia to consider and approve the audited financial results of the Company for the quarter and year ended 31st March 2022 alongwith the report of statutory auditor thereon. This is to inform you that the Board of Directors of Kobo Biotech Limited at their meeting held today i.e. on Monday, 30th May, 2022 inter alia approved the Audited Financial Results of the Company for the quarter and year ended 31st March, 2022 alongwith the report of statutory auditor thereon. (As Per BSE Announcement Dated on 30/05/2022)
02-Feb-2022	14-Feb-2022	Quarterly Results	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve Unaudited Financial Results For The Quarter And Nine Month Ended 31st December 2021. This is to inform you that the Board of Directors of Kobo Biotech Limited at their meeting held today i.e. on Monday, 14th February, 2022 inter alia approved the Unaudited Financial Results of the Company for the quarter and nine-month ended 31st December 2021 along with the Limited review report of statutory auditor thereon. (As Per BSE Announcement Dated 14.02.2022)
01-Nov-2021	08-Nov-2021	Quarterly Results	Quarterly Results
06-Aug-2021	13-Aug-2021	Quarterly Results	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 inter alia to consider and approve the unaudited financial results of the Company for the 1st quarter ended 30th June 2021 This is to inform you that the Board of Directors of Kobo Biotech Limited at their meeting held today i.e. on Friday, 13th August 2021 inter alia approved the Unaudited Financial Results of the Company for the quarter ended 30th June 2021 along with the Limited review report of statutory auditor thereon. (As Per BSE Announcement dated on 13.08.2021)
24-Jun-2021	30-Jun-2021	Accounts	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve the audited financial results of the Company for the quarter and year ended 31st March 2021 along with the report of statutory auditor thereon. The Board of Directors of Kobo Biotech Limited at their meeting held today i.e. on Wednesday, 30th June, 2021 inter alia approved the Audited Financial Results of the Company for the quarter and year ended 31st March, 2021 alongwith the report of statutory auditor thereon. (As per BSE Announcement Dated on 30/06/2021)
05-Feb-2021	12-Feb-2021	Quarterly Results	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve the unaudited financial results of the Company for the quarter and nine month ended 31st December, 2020 alongwith the limited review report of statutory auditor thereon. The Board of Directors of Kobo Biotech Limited at their meeting held today i.e. on Friday, 12th February, 2021 inter alia approved the Unaudited Financial Results of the Company for the quarter and nine month ended 31st December, 2020 alongwith the limited review report of statutory auditor thereon. (AS Per BSE Announcement Dated on 12.02.2021)

1 2

LOGIN HERE

Kobo Biotech Ltd

Board Meeting